| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Acticor Biotech SA
PAR:ALACT
Acticor Biotech SA
Selling, General & Administrative
Acticor Biotech SA
Selling, General & Administrative Peer Comparison
VLA
NANO
IPH
ABVX
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Acticor Biotech SA
PAR:ALACT
|
Selling, General & Administrative
-€3.3m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Valneva SE
PAR:VLA
|
Selling, General & Administrative
-€146.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nanobiotix SA
PAR:NANO
|
Selling, General & Administrative
-€21.7m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-20%
|
|
|
Innate Pharma SA
PAR:IPH
|
Selling, General & Administrative
-€16.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-8%
|
|
G
|
Genfit SA
PAR:GNFT
|
Selling, General & Administrative
-€8.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
Abivax SA
PAR:ABVX
|
Selling, General & Administrative
-€28.8m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
See Also
What is Acticor Biotech SA's Selling, General & Administrative?
Selling, General & Administrative
-3.3m
EUR
Based on the financial report for Jun 30, 2023, Acticor Biotech SA's Selling, General & Administrative amounts to -3.3m EUR.
What is Acticor Biotech SA's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
14%
Over the last year, the Selling, General & Administrative growth was 22%. The average annual Selling, General & Administrative growth rates for Acticor Biotech SA have been -38% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
